← SynDRA
CLENBUTEROL
SynDRA canonical compound SYN0002408 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | ADRB2 |
| Mechanism of action | Adrenergic receptor agonist |
| Indication | asthma | chronic obstructive pulmonary disease (COPD) |
| Disease area | pulmonary |
All known targets
- ADRB2
- ADRB1
- ABCC8
- HTR1A
- Htr1a
- KCNJ11
Mechanisms of action (all sources)
- Adrenergic receptor agonist
- ADRB2 AGONIST
- Beta-2 adrenergic receptor agonist
- ADRB1 FULL AGONIST
- ADRB2 FULL AGONIST
Drug classes
- Adrenergic Agents
- Adrenergic Agonists
- Adrenergic beta-Agonists
- Anti-Asthmatic Agents
- Bronchodilator Agents
- Neurotransmitter Agents
- Peripheral Nervous System Agents
- Respiratory System Agents
- Sympathomimetics
ATC classes
- R03A · ADRENERGICS, INHALANTS
- R03C · ADRENERGICS FOR SYSTEMIC USE
Cross-references
Synonyms
- (RS)-Clenbuterol
- (+/-)-Clenbuterol
- planipart
- dl-Clenbuterol
- clenbuterol hydrochloride
- clenbuterol HCl
- Contraspasmin
- Planipart
- NAB-365
- NSC-758633
- Spiropent
- Spiropent mite
- Clenbuterolum
- Planipart [veterinary]
- Clenbuterol (INN)
- Clenbuterol [BAN:INN]
- Clenbuterolum [INN-Latin]
- Contraspasmin (TN)
- Planipart [veterinary] (TN)
- (+)-4-Amino-alpha-((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol
- (+-)-clenbuterol
- (-)-4-Amino-alpha-((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol
- 1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol
- 1-(4-Amino-3,5-dichlorophenyl)-2-(tert-butylamino)ethanol
- 1-(4-amino-3,5-dichlorophenyl)-2-[(1,1-dimethylethyl)amino]ethanol
- 4-Amino-3,5-dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol
- 4-Amino-alpha-((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol
- Monores
- NAB 365
- (+/-)-clenbuterol
- XTZ6AXU7KN
- 1-(4-amino-3,5-dichlorophenyl)-2-(tert-butylamino)ethan-1-ol
- CHEBI:174690
- P 5369
- NSC 758633
- NCGC00163150-01
- CLENBUTEROL [INN]
- 4-Amino-alpha-((tert-butylamino)methyl)-3,5-dichlorobenzyl alcoho
Look up CLENBUTEROL in the interactive SynDRA portal →